HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anticonvulsant action of GABA-B receptor agonist SKF97541 differs from that of baclofen.

Abstract
GABA-B receptor agonist SKF97541 exhibits age-dependent anticonvulsant and proconvulsant actions in developing rats. It suppressed tonic phase of generalized seizures induced by pentetrazol in 7-, 12- and 18-day-old rats and increased their latency in 7- and 12-day-old animals. Other results in 18-day-old animals are not so clear. SKF97541 blocked the appearance of minimal clonic seizures, but tended to decrease latencies of both types of seizures. In addition, it significantly decreases latency of generalized seizures in adult rats. The mixed effects of SKF97541 are in agreement with those of baclofen but there are substantial differences between the actions of these two agonists in individual age groups.
AuthorsP Mares
JournalPhysiological research (Physiol Res) Vol. 57 Issue 5 Pg. 789-792 ( 2008) ISSN: 0862-8408 [Print] Czech Republic
PMID17949247 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticonvulsants
  • GABA Agonists
  • GABA-B Receptor Agonists
  • Organophosphorus Compounds
  • Receptors, GABA-B
  • 3-aminopropyl(methyl)phosphinic acid
  • Baclofen
  • Pentylenetetrazole
Topics
  • Age Factors
  • Animals
  • Anticonvulsants (pharmacology)
  • Baclofen (pharmacology)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • GABA Agonists (pharmacology)
  • GABA-B Receptor Agonists
  • Male
  • Organophosphorus Compounds (pharmacology)
  • Pentylenetetrazole
  • Rats
  • Rats, Wistar
  • Reaction Time (drug effects)
  • Receptors, GABA-B (metabolism)
  • Seizures (chemically induced, metabolism, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: